1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GILEAD SCIENCES, INC.
Gilead Sciences, Inc.
XNAS: GILD

Gilead Sciences Live Stock Price Today, Share Analysis and Chart

Risky Value
about

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Read More
139.77 -0.68 (-0.48%)
49.69% Gain from 52W Low
3.8M
XNAS Volume

XNAS 15 Apr, 2026 4:09 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Gilead Sciences is on 24 Apr 2026 for the purpose of Gilead Sciences Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Affordable Valuation
52.0 / 100
Momentum Score
Technically Neutral
57.1 / 100
Risky Value These stocks have weak financials and average momentum. They may be affordable, but investors should exercise caution View Similar Embed DVM
Analyst Price Target
158
1Yr Price target upside is 13%
28 analysts

9

S

5

W

5

O

1

T

SWOT Analysis

Gilead Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..